Concerns over Ozempic misuse and eating disorder risks prompt calls for increased screening
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity
Vivani Medical, Inc. (NASDAQ:VANI) announced the administration of its first GLP-1 (exenatide, NPM-115) implant in the ...
pharmaphorum21h
Regulators vs weight loss ads: Time to rethink the rules?
Certain companies seem particularly relentless. Their ads don’t explicitly name the drugs they prescribe, but they don’t need to. Suggestive phrases like “doctor-supported weight loss” and “clinically ...
‘Everything at some point was impossible’: Inside Bryan Johnson’s quest to live forever
If you haven’t heard of Bryan Johnson or watched the Netflix documentary about him (it’s called Don’t Die: The Man Who Wants ...
In basketball and in business, this MD knows when to take the shot
A lifetime of playing has taught Lawrence Lam that the best opportunities reveal themselves when you stay patient and read ...
Forbes14h
Convert United States Dollar To Australian Dollar
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
Forbes23h
Convert Australian Dollar To United States Dollar
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.